Thiol repletion prevents venous thrombosis in rats by nitric oxide/prostacyclin-dependent mechanism: Relation to the antithrombotic action of captopril

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 4, 2000, Pages 503-509

  Pawlak, Robert ^a   Chabielska, Ewa ^a   Matys, Tomasz ^a   Kucharewicz, Iwona ^a   Rółkowski, Roland ^b   Buczko, Wodzimierz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Centre of Oncology   (Poland)

Author keywords

Nitric oxide; Prostacyclin; Rat; Thiol group; Thrombosis

Indexed keywords

ACETYLCYSTEINE; CAPTOPRIL; ENALAPRIL; EPICAPTOPRIL; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTACYCLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; FIBRINOLYSIS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RAT; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOGENESIS; VEIN THROMBOSIS;

EID: 0033801748     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200010000-00014     Document Type: Article

References (27)

1. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II: Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function
2. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells: A potential link between the renin-angiotensin system and thrombosis
3. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells
4. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival And Ventricular Enlargement trial
5. Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction
6. Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta
7. Effect of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction
8. Nitric oxide and prostacyclin are involved in antithrombotic activity of captopril in venous thrombosis in rats
9. A low-cost tail-cuff method for the estimation of mean arterial pressure in conscious rats
10. Bleeding time in rats: A comparison of different experimental conditions
11. Venostasis-induced thrombosis in rat is not influenced by circulating platelet or leukocyte number
12. Sodium nitroprusside modulates the fibrinolytic system in the rabbit
13. Effects of drags affecting the renin-angiotensin system on venous thrombosis in normotensive rats
14. Inhibition of platelet activation by 2-mercaptopropionylglycin in vitro and in vivo
15. Effect of lisinopril and hydrochlorothiazide on platelet function and blood rheology in essential hypertension: A randomly allocated double-blind study
16. Modification of blood coagulation by antihypertensive therapy: Effect of enalapril and hydrochlorothiazide on blood coagulation parameters in patients with essential hypertension
17. Cyclic strain-induced plasminogen activator inhibitor-1 (PAI-1) release from endothelial cells involves reactive oxygen species
18. The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy
19. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients
20. Effect of N-acetylcysteine on fibrin deposition in the rat lung due to intravascular coagulation
21. Effect of N-acetylcysteine on pulmonary damage due to microembolism in the rat
22. Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols
23. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin
24. S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups
25. Interactions between endothelial mediators
26. Suppressive effect of captopril on platelet aggregation in essential hypertension
27. Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols